The double test for pharmaceutical trademarks

      The « European MEdicines Agency », « EMEA »,(for the Community) – and the « French Health Products Safety Agency « AFSSAPS » (for France) – ascertain that, in the application for trade authorization, proposed pharmaceutical trademarks are not confusingly similar to other existing trademarks and cannot generate confusion as to the quality or properties of the pharmaceuticals and …

The double test for pharmaceutical trademarks Lire la suite »